PRLog - April 24, 2012 - NEEDHAM, Mass. -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Affiliated Reports Collection announces the Biomarker Partnering Terms and Agreements Report, published by Current Partnering.
This report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.
• In-depth understanding of biomarker deal trends since 2005
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of biomarker agreements with numerous real life case studies
• Comprehensive access to over 1000 actual biomarker contracts entered into by the world’s biopharma companies
• Detailed access to actual biomarker contracts enter into by the leading fifty bigpharma companies
• Insight into the terms included in a biomarker agreement, together with real world clause examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/